Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

Early diagnosis and treatment of favus can prevent permanent hair loss.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Frontal fibrosing alopecia has a higher remission rate than lichen planopilaris.

Dermoscopic features can help identify and differentiate types of pityriasis versicolor.

A woman with a rare scalp infection was cured after one month of medication.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

The protocol is easy to use, but reliable results need the same person to assess each time.

Cosmetic products or emotional factors might contribute to Frontal Fibrosing Alopecia, and trichoscopy is useful for diagnosis.

The evaluation system improved patient selection for hair loss surgery, leading to better results and satisfaction.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Trichoscopy is a useful non-invasive method to diagnose female hair loss with high accuracy.

Dermoscopic and histopathological features combined can help diagnose Pityriasis versicolor.

The methods tested are reliable for assessing dandruff reduction.

Frontal fibrosing alopecia and vitiligo might be linked, not just coincidental.

Tangent screens help detect visual field defects from vigabatrin.

High-quality validation studies are needed to improve alopecia areata patient-reported outcome measures.

Young patients with Vogt-Koyanagi-Harada syndrome may have poor vision outcomes despite treatment due to frequent recurrences.

Women with severe frontal fibrosing alopecia are more likely to have rosacea.

A reliable severity score for female pattern hair loss was developed and validated.

The FG score is better at detecting hyperandrogenism in PCOS patients than testosterone levels or FAI, but testosterone is the recommended test for diagnosis.

Self-assessed hirsutism scores are not reliable for clinical diagnosis but may help in screening.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.